Plasma is a composite mixture of more than 700 proteins and other substances which are vital for the smooth functioning of the human body. Plasma is the liquid component of blood, constituting around 50% of the total blood volume. Plasma in itself is approximately 90% water, with the remaining 10% comprising of proteins, minerals, clotting factors, hormones and immunoglobulin which are used for their therapeutic values.
Browse Full Report With Toc: http://www.marketresearchreports.biz/analysis-details/global-blood-plasma-market-report-2014-edition
With the swift changes and advancement in biomedical/healthcare technology, the healthcare/pharmaceutical/therapeutic industry is becoming ever more competitive. Also, increasing incidences of health related issues owing to changing lifestyles is augmenting the blood plasma industry’s growth. In order to address the rising medical needs related to blood disorders such as autoimmune diseases and liver function impairment among others, market players are coming up with novel and improved treatment options like IVIG, albumin, clotting factors etc. which are derived from human blood plasma.
The blood plasma market is highly regulated to ensure the safety of collected plasma and protect donors. The market is characterized by fast pace developments in the clinical technology and testing methodology. The report, “Global Blood Plasma Market” presents different facets of the global blood plasma market with a focus on sub-markets like IVIG, albumin and hemophilia market. Moreover, market dynamics like the key trends, industry developments, growth drivers and challenges are analyzed in detail.
To Get Download Full Report with Toc: http://www.marketresearchreports.biz/sample/sample/210875
Furthermore, the competitive landscape of the industry is presented. The market remains highly concentrated and is dominated by a handful of players including CSL, Grifols, Baxter and Octapharma. The profiles of these leading players are also included in the report along with their key financials and strategies for growth.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have projected the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables, and tests.
Table of Content
1. Overview
1.1 Components of Blood Plasma
1.2 Functions of Blood Plasma
1.3 Collection and Extraction of Plasma
1.3.1 Plasma Collection
1.3.2 Plasma Extraction
1.3.3 Plasma Fractionation Yield
1.3.4 Plasma Usage
To Read Complete Report with Toc: http://www.marketresearchreports.biz/analysis/210875
2. Blood Plasma Market Analysis
2.1 Global Plasma Market
Market Value
Market Segmentation
Breakdown by Region
2.1.1 Plasma Industry Cost Structure
2.2 Global Immunoglobulin (Ig) Market
Market Value
Market Volume
Demand & Supply
Volume by Region
Per Capita Usage
2.3 Global Hemophilia Market
Total Market Value
Hemophilia A Market
FVIII Demand & Usage
Hemophilia B Market
FIX Consumption
Hemophilia with Inhibitor Market
Von Willebrand Disease Market
2.4 Global Albumin Market
2.4.1 Albumin Market of China and the US
3. Market Dynamics
3.1 Key Trends
3.1.1 Kinetics of Plasma-collection Industry
3.1.2 Growth in the US Immunoglobulin Reimbursement
3.1.3 Rise in the US Plasma Collection Centers
3.1.4 Rising Penetration of Episodic Treatment in Emerging Markets
3.1.5 Rising Share of Developing World in Global FVIII Demand
3.1.6 A1PI (Alpha-1 Proteinase Inhibitor) Deficiency- Confined to Prevention only
3.2 Industry Developments
3.2.1 Improved Biological Molecule Formulations
3.2.2 Baxter’s Phase I Clinical Trial of Treatment for Hemophilia A
3.2.3 Global Fractionation Capacity on the Rise
3.3 Growth Drivers
3.3.1 Increasing New Patient Registration for Hemophilia Treatment
3.3.2 Increased Penetration of Plasma Derived Products
3.3.3 Rising Healthcare Expenditure
3.3.4 Launch of NMEs (New Molecular Entities)
3.3.5 Growing Ageing Population
3.3.6 Ameliorating Economic Conditions
3.3.7 China Factor
3.4 Challenges
3.4.1 Increasing Regulation in Plasma-collection Industry
3.4.2 Escalating Price Pressure
3.4.3 Supply Likely to Exceed Demand
3.4.4 Misdiagnosis of the Disease
Contact US:
Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Toll Free: 866-997-4948
Tel: +1-518-618-1030
E: sales@marketresearchreports.biz
No comments:
Post a Comment